Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
144
datasets available to search
ShareScore release 0.9.0
Dataset results
144 results for “anti-VEGF”
Genetic association analysis of anti-VEGF treatment response in neovascular age-related macular degeneration
<p>Summary statisics of an association study of 6,908,005 genetic variants with anti-VEGF nAMD treatment response in 179 treatment-naïve nAMD probands. This dataset supplements the publication "Genetic Association Analysis of Anti-VEGF Treatment Response in Neovascular Age-Related Macular Degeneration" (DOI: 10.3390/ijms23116094). Details regarding the methods and version numbers can be found in the corresponding manuscript.</p>
Comparing Single Versus Multiple Anti-VEGF Injections in Diabetic Patients Undergoing Cataract Surgery
ClinicalTrials.gov study NCT07301775. IPD Sharing: YES. Countries: 1. Publications: 14.
Vascular Endothelial Growth Factor (VEGF) Levels in Retinal Vein Occlusion (RVO) During Anti-VEGF Treatment
ClinicalTrials.gov study NCT04707625. IPD Sharing: NO. Countries: 1. Publications: 4.
Phase II Combination Steroid and Anti-VEGF for Persistent DME
ClinicalTrials.gov study NCT01945866. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT01213082. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Anti-VEGF Treatment for Prevention of PDR/DME
ClinicalTrials.gov study NCT02634333. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema
ClinicalTrials.gov study NCT00682539. IPD Sharing: NO. Countries: 1. Publications: 2.
ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00312377. IPD Sharing: Not stated. Countries: 25. Publications: 4.
INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD
ClinicalTrials.gov study NCT01016873. IPD Sharing: Not stated. Countries: 5. Publications: 1.
A Study to Establish the Safety and Tolerability of Zimura™ (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)
ClinicalTrials.gov study NCT02397954. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT00511706. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Comparison of Intravitreal Anti-VEGF Versus Combination Therapy in Central Retinal Vein Occlusion
ClinicalTrials.gov study NCT04812977. IPD Sharing: NO. Countries: 1. Publications: 2.
Evaluation of the Effect of Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using OCTA
ClinicalTrials.gov study NCT03246152. IPD Sharing: NO. Countries: 1. Publications: 17.
A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin)
ClinicalTrials.gov study NCT00336323. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
ClinicalTrials.gov study NCT02858076. IPD Sharing: Not stated. Countries: 2. Publications: 3.
Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF
ClinicalTrials.gov study NCT02118831. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Prospective Study of Adjunctive Carotenoids Plus Anti-oxidants in Anti-VEGF Treated Diabetic Macular Edema
ClinicalTrials.gov study NCT03866005. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
ClinicalTrials.gov study NCT03710564. IPD Sharing: YES. Countries: 2. Publications: 0.
Seven-year Outcomes Following Intensive Anti-VEGF Therapy in Wet AMD
ClinicalTrials.gov study NCT05678517. IPD Sharing: NO. Countries: 1. Publications: 1.
Anti-VEGF Therapy for Acute Thyroid Eye Disease
ClinicalTrials.gov study NCT04311606. IPD Sharing: YES. Countries: 1. Publications: 8.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.